Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Silvan Tuerkcan's Stock Ratings
Citizens Analyst
Silvan Tuerkcan is an analyst at Citizens. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
19.6%
Smart Score
Overall Average Return Percentile
76th
Number of Ratings
222
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/11/2025 | TERN | Buy Now | Terns Pharma | $44.31 | 28.62% | $35 → $57 | Maintains | Market Outperform | Get Alert | |
| 11/26/2025 | TERN | Buy Now | Terns Pharma | $44.31 | -21.02% | $25 → $35 | Maintains | Market Outperform | Get Alert | |
| 11/20/2025 | NUVB | Buy Now | Nuvation Bio | $8.43 | 18.62% | $8 → $10 | Maintains | Market Outperform | Get Alert | |
| 11/12/2025 | ENGN | Buy Now | enGene Holdings | $8.66 | 142.43% | $18 → $21 | Maintains | Market Outperform | Get Alert | |
| 11/07/2025 | NTLA | Buy Now | Intellia Therapeutics | $9.18 | 128.88% | $29 → $21 | Maintains | Market Outperform | Get Alert | |
| 11/05/2025 | TSHA | Buy Now | Taysha Gene Therapies | $5.81 | 37.69% | $6 → $8 | Maintains | Market Outperform | Get Alert | |
| 11/04/2025 | NUVB | Buy Now | Nuvation Bio | $8.43 | -5.1% | $6 → $8 | Maintains | Market Outperform | Get Alert | |
| 11/04/2025 | BNTC | Buy Now | Benitec Biopharma | $12.16 | 80.85% | $20 → $22 | Maintains | Market Outperform | Get Alert | |
| 10/28/2025 | NTLA | Buy Now | Intellia Therapeutics | $9.18 | 216.08% | $33 → $29 | Maintains | Market Outperform | Get Alert | |
| 10/23/2025 | TERN | Buy Now | Terns Pharma | $44.31 | -66.15% | $20 → $15 | Maintains | Market Outperform | Get Alert | |
| 10/06/2025 | NTLA | Buy Now | Intellia Therapeutics | $9.18 | 259.67% | → $33 | Upgrade | Market Perform → Market Outperform | Get Alert | |
| 09/24/2025 | BNTC | Buy Now | Benitec Biopharma | $12.16 | 64.41% | $20 → $20 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 09/22/2025 | JSPR | Buy Now | Jasper Therapeutics | $1.69 | 256.08% | $12 → $6 | Maintains | Market Outperform | Get Alert | |
| 09/19/2025 | NTLA | Buy Now | Intellia Therapeutics | $9.18 | — | — | Reiterates | Market Perform → Market Perform | Get Alert | |
| 09/08/2025 | PHR | Buy Now | Phreesia | $16.21 | 109.75% | $30 → $34 | Maintains | Market Outperform | Get Alert | |
| 09/08/2025 | IDYA | Buy Now | IDEAYA Biosciences | $33.92 | 32.65% | $41 → $45 | Maintains | Market Outperform | Get Alert | |
| 09/04/2025 | IDYA | Buy Now | IDEAYA Biosciences | $33.92 | 20.85% | → $41 | Initiates | → Market Outperform | Get Alert | |
| 07/29/2025 | EXEL | Buy Now | Exelixis | $41.49 | 20.51% | $50 → $50 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 07/08/2025 | JSPR | Buy Now | Jasper Therapeutics | $1.69 | 612.17% | $70 → $12 | Maintains | Market Outperform | Get Alert | |
| 06/27/2025 | CRSP | Buy Now | CRISPR Therapeutics | $57.49 | 49.59% | $86 → $86 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 06/25/2025 | NUVB | Buy Now | Nuvation Bio | $8.43 | -28.83% | $6 → $6 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 06/23/2025 | EXEL | Buy Now | Exelixis | $41.49 | 20.51% | $47 → $50 | Maintains | Market Outperform | Get Alert | |
| 06/10/2025 | ELEV | Buy Now | Elevation Oncology | — | — | — | Reiterates | Market Perform → Market Perform | Get Alert | |
| 06/06/2025 | SLDB | Buy Now | Solid Biosciences | $5.77 | 159.97% | $15 → $15 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 06/02/2025 | NUVB | Buy Now | Nuvation Bio | $8.43 | -28.83% | $6 → $6 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 05/29/2025 | TSHA | Buy Now | Taysha Gene Therapies | $5.81 | 3.27% | $5 → $6 | Maintains | Market Outperform | Get Alert | |
| 05/21/2025 | CRSP | Buy Now | CRISPR Therapeutics | $57.49 | 49.59% | $86 → $86 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 05/20/2025 | PRME | Buy Now | Prime Medicine | $4.13 | 45.1% | $10 → $6 | Maintains | Market Outperform | Get Alert | |
| 05/15/2025 | FHTX | Buy Now | Foghorn Therapeutics | $4.49 | 100.45% | $9 → $9 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 05/15/2025 | BNTC | Buy Now | Benitec Biopharma | $12.16 | 64.41% | $20 → $20 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 05/09/2025 | VOR | Buy Now | Vor Biopharma | $13.40 | -55.22% | $6 → $6 | Downgrade | Market Outperform → Market Perform | Get Alert | |
| 04/30/2025 | FHTX | Buy Now | Foghorn Therapeutics | $4.49 | 100.45% | $9 → $9 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 04/29/2025 | ENGN | Buy Now | enGene Holdings | $8.66 | 107.8% | $18 → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 04/28/2025 | TSHA | Buy Now | Taysha Gene Therapies | $5.81 | -13.94% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 04/23/2025 | FHTX | Buy Now | Foghorn Therapeutics | $4.49 | 100.45% | → $9 | Initiates | → Market Outperform | Get Alert | |
| 04/23/2025 | NUVB | Buy Now | Nuvation Bio | $8.43 | -28.83% | → $6 | Initiates | → Market Outperform | Get Alert | |
| 04/21/2025 | TERN | Buy Now | Terns Pharma | $44.31 | -54.87% | $20 → $20 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 04/17/2025 | EXEL | Buy Now | Exelixis | $41.49 | -1.18% | $41 → $41 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 04/10/2025 | BNTC | Buy Now | Benitec Biopharma | $12.16 | 64.41% | $18 → $20 | Maintains | Market Outperform | Get Alert | |
| 03/26/2025 | ACRV | Buy Now | Acrivon Therapeutics | $2.52 | 574.6% | $17 → $17 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 03/21/2025 | ELEV | Buy Now | Elevation Oncology | — | — | — | Reiterates | Market Outperform → Market Perform | Get Alert | |
| 03/21/2025 | ELEV | Buy Now | Elevation Oncology | — | — | $7 → $7 | Downgrade | Market Outperform → Market Perform | Get Alert | |
| 03/18/2025 | BNTC | Buy Now | Benitec Biopharma | $12.16 | 47.97% | $18 → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 03/14/2025 | GBIO | Buy Now | Generation Bio | $5.36 | — | — | Reiterates | Market Perform → Market Perform | Get Alert | |
| 03/10/2025 | ELEV | Buy Now | Elevation Oncology | — | — | $7 → $7 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 03/07/2025 | SLDB | Buy Now | Solid Biosciences | $5.77 | 159.97% | $15 → $15 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 03/04/2025 | PRME | Buy Now | Prime Medicine | $4.13 | 141.84% | $10 → $10 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 02/13/2025 | CRSP | Buy Now | CRISPR Therapeutics | $57.49 | 49.59% | $86 → $86 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 01/27/2025 | EXEL | Buy Now | Exelixis | $41.49 | -1.18% | $41 → $41 | Maintains | Market Outperform | Get Alert | |
| 01/23/2025 | EXEL | Buy Now | Exelixis | $41.49 | -1.18% | $41 → $41 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 01/15/2025 | EXEL | Buy Now | Exelixis | $41.49 | -1.18% | $34 → $41 | Maintains | Market Outperform | Get Alert | |
| 01/10/2025 | JSPR | Buy Now | Jasper Therapeutics | $1.69 | 4054.3% | $70 → $70 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 01/08/2025 | CNTX | Buy Now | Context Therapeutics | $1.05 | 280.95% | → $4 | Initiates | → Market Outperform | Get Alert | |
| 01/06/2025 | JSPR | Buy Now | Jasper Therapeutics | $1.69 | 4054.3% | $70 → $70 | Maintains | Market Outperform | Get Alert | |
| 12/23/2024 | ENGN | Buy Now | enGene Holdings | $8.66 | 107.8% | $18 → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 12/20/2024 | CRSP | Buy Now | CRISPR Therapeutics | $57.49 | 49.59% | $86 → $86 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 12/19/2024 | ELEV | Buy Now | Elevation Oncology | — | — | $7 → $7 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 12/12/2024 | RLAY | Buy Now | Relay Therapeutics | $8.22 | 155.32% | $21 → $21 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 12/10/2024 | VOR | Buy Now | Vor Biopharma | $13.40 | -10.45% | $12 → $12 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 12/10/2024 | SLDB | Buy Now | Solid Biosciences | $5.77 | 159.97% | → $15 | Initiates | → Market Outperform | Get Alert | |
| 12/10/2024 | PRME | Buy Now | Prime Medicine | $4.13 | 141.84% | → $10 | Initiates | → Market Outperform | Get Alert | |
| 12/06/2024 | ENGN | Buy Now | enGene Holdings | $8.66 | 107.8% | $18 → $18 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 12/04/2024 | TERN | Buy Now | Terns Pharma | $44.31 | -54.87% | $20 → $20 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 11/18/2024 | ENGN | Buy Now | enGene Holdings | $8.66 | 107.8% | → $18 | Initiates | → Market Outperform | Get Alert | |
| 11/12/2024 | TSHA | Buy Now | Taysha Gene Therapies | $5.81 | -13.94% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 11/07/2024 | MGNX | Buy Now | Macrogenics | $1.40 | — | — | Downgrade | Market Outperform → Market Perform | Get Alert | |
| 10/16/2024 | EXEL | Buy Now | Exelixis | $41.49 | -18.05% | $29 → $34 | Maintains | Market Outperform | Get Alert | |
| 10/15/2024 | JSPR | Buy Now | Jasper Therapeutics | $1.69 | 4054.3% | $70 → $70 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 10/14/2024 | BNTC | Buy Now | Benitec Biopharma | $12.16 | 47.97% | $16 → $18 | Maintains | Market Outperform | Get Alert | |
| 10/11/2024 | EXEL | Buy Now | Exelixis | $41.49 | -30.1% | $29 → $29 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 09/30/2024 | BNTC | Buy Now | Benitec Biopharma | $12.16 | 31.52% | $16 → $16 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 09/27/2024 | JSPR | Buy Now | Jasper Therapeutics | $1.69 | 4054.3% | $70 → $70 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 09/20/2024 | EXEL | Buy Now | Exelixis | $41.49 | -30.1% | $29 → $29 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 09/20/2024 | NTBL | Buy Now | Notable Labs | — | — | — | Downgrade | Market Outperform → Market Perform | Get Alert | |
| 09/17/2024 | RLAY | Buy Now | Relay Therapeutics | $8.22 | 155.32% | $21 → $21 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 09/16/2024 | ACRV | Buy Now | Acrivon Therapeutics | $2.52 | 574.6% | $17 → $17 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 09/10/2024 | TERN | Buy Now | Terns Pharma | $44.31 | -54.87% | $15 → $20 | Maintains | Market Outperform | Get Alert | |
| 09/09/2024 | JSPR | Buy Now | Jasper Therapeutics | $1.69 | 4054.3% | → $70 | Initiates | → Market Outperform | Get Alert | |
| 09/06/2024 | VOR | Buy Now | Vor Biopharma | $13.40 | -10.45% | $12 → $12 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 09/03/2024 | TERN | Buy Now | Terns Pharma | $44.31 | -66.15% | $15 → $15 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 08/07/2024 | EXEL | Buy Now | Exelixis | $41.49 | -30.1% | $27 → $29 | Maintains | Market Outperform | Get Alert | |
| 07/31/2024 | MGNX | Buy Now | Macrogenics | $1.40 | 471.43% | $16 → $8 | Maintains | Market Outperform | Get Alert | |
| 07/18/2024 | RLAY | Buy Now | Relay Therapeutics | $8.22 | 155.32% | $24 → $21 | Maintains | Market Outperform | Get Alert | |
| 07/15/2024 | ELEV | Buy Now | Elevation Oncology | — | — | $7 → $7 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 06/28/2024 | ELEV | Buy Now | Elevation Oncology | — | — | $7 → $7 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 06/20/2024 | TSHA | Buy Now | Taysha Gene Therapies | $5.81 | -13.94% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 05/31/2024 | CLLS | Buy Now | Cellectis | $4.73 | 26.85% | $6 → $6 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 05/13/2024 | VOR | Buy Now | Vor Biopharma | $13.40 | -10.45% | $12 → $12 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 05/10/2024 | MGNX | Buy Now | Macrogenics | $1.40 | 1042.86% | $22 → $16 | Maintains | Market Outperform | Get Alert | |
| 05/09/2024 | CRSP | Buy Now | CRISPR Therapeutics | $57.49 | 49.59% | $86 → $86 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 05/06/2024 | RLAY | Buy Now | Relay Therapeutics | $8.22 | 191.79% | $24 → $24 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 04/30/2024 | TERN | Buy Now | Terns Pharma | $44.31 | -66.15% | $15 → $15 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 04/25/2024 | ACRV | Buy Now | Acrivon Therapeutics | $2.52 | 574.6% | $14 → $17 | Maintains | Market Outperform | Get Alert | |
| 04/22/2024 | BNTC | Buy Now | Benitec Biopharma | $12.16 | 31.52% | $10 → $16 | Maintains | Market Outperform | Get Alert | |
| 04/15/2024 | NTBL | Buy Now | Notable Labs | — | — | $9 → $9 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 04/10/2024 | EXEL | Buy Now | Exelixis | $41.49 | -34.92% | $27 → $27 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 04/04/2024 | MGNX | Buy Now | Macrogenics | $1.40 | — | — | Reiterates | → Market Outperform | Get Alert | |
| 04/01/2024 | ACRV | Buy Now | Acrivon Therapeutics | $2.52 | 455.56% | $14 → $14 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 03/22/2024 | VOR | Buy Now | Vor Biopharma | $13.40 | -10.45% | $12 → $12 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 03/20/2024 | TSHA | Buy Now | Taysha Gene Therapies | $5.81 | -13.94% | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 03/18/2024 | TERN | Buy Now | Terns Pharma | $44.31 | -66.15% | $17 → $15 | Maintains | Outperform | Get Alert | |
| 03/11/2024 | MGNX | Buy Now | Macrogenics | $1.40 | 1471.43% | $16 → $22 | Maintains | Outperform | Get Alert | |
| 03/07/2024 | ELEV | Buy Now | Elevation Oncology | — | — | → $7 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 03/05/2024 | MNDY | Buy Now | Monday.Com | $153.88 | 81.96% | $240 → $280 | Maintains | Buy | Get Alert | |
| 03/01/2024 | ELEV | Buy Now | Elevation Oncology | — | — | → $7 | Initiates | → Market Outperform | Get Alert | |
| 03/01/2024 | ACRV | Buy Now | Acrivon Therapeutics | $2.52 | 455.56% | → $14 | Initiates | → Market Outperform | Get Alert | |
| 02/15/2024 | BNTC | Buy Now | Benitec Biopharma | $12.16 | -17.8% | $8 → $10 | Maintains | Market Outperform | Get Alert | |
| 01/24/2024 | MGNX | Buy Now | Macrogenics | $1.40 | 1042.86% | $10 → $16 | Maintains | Market Outperform | Get Alert | |
| 01/24/2024 | BNTC | Buy Now | Benitec Biopharma | $12.16 | -34.24% | $6 → $8 | Maintains | Market Outperform | Get Alert | |
| 12/19/2023 | NTBL | Buy Now | Notable Labs | — | — | $13 → $9 | Maintains | Market Outperform | Get Alert | |
| 12/14/2023 | EXEL | Buy Now | Exelixis | $41.49 | -34.92% | $27 → $27 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 12/11/2023 | CRSP | Buy Now | CRISPR Therapeutics | $57.49 | 39.15% | $74 → $80 | Maintains | Market Outperform | Get Alert | |
| 12/05/2023 | TERN | Buy Now | Terns Pharma | $44.31 | -61.64% | → $17 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 12/05/2023 | CRSP | Buy Now | CRISPR Therapeutics | $57.49 | 28.72% | → $74 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 11/13/2023 | EXEL | Buy Now | Exelixis | $41.49 | -34.92% | → $27 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 11/01/2023 | CLLS | Buy Now | Cellectis | $4.73 | 26.85% | $6 → $6 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 10/23/2023 | GBIO | Buy Now | Generation Bio | $5.36 | — | — | Downgrade | Market Outperform → Market Perform | Get Alert | |
| 10/18/2023 | NTBL | Buy Now | Notable Labs | — | — | → $13 | Initiates | → Market Outperform | Get Alert | |
| 10/09/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | — | Downgrade | Market Outperform → Market Perform | Get Alert | |
| 10/06/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | $58 → $82 | Maintains | Market Outperform | Get Alert | |
| 10/04/2023 | MNDY | Buy Now | Monday.Com | $153.88 | 55.97% | $210 → $240 | Maintains | Buy | Get Alert | |
| 09/28/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $58 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 09/26/2023 | BNTC | Buy Now | Benitec Biopharma | $12.16 | -50.68% | $4 → $6 | Maintains | Market Outperform | Get Alert | |
| 08/22/2023 | EXEL | Buy Now | Exelixis | $41.49 | -34.92% | $24 → $27 | Maintains | Outperform | Get Alert | |
| 08/15/2023 | TSHA | Buy Now | Taysha Gene Therapies | $5.81 | -31.15% | → $4 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 08/14/2023 | VOR | Buy Now | Vor Biopharma | $13.40 | -10.45% | → $12 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 08/07/2023 | CLLS | Buy Now | Cellectis | $4.73 | 26.85% | → $6 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 08/02/2023 | EXEL | Buy Now | Exelixis | $41.49 | -42.15% | → $24 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 07/26/2023 | TERN | Buy Now | Terns Pharma | $44.31 | -61.64% | → $17 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 07/25/2023 | CRSP | Buy Now | CRISPR Therapeutics | $57.49 | 28.72% | → $74 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 07/19/2023 | EXEL | Buy Now | Exelixis | $41.49 | -42.15% | → $24 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 06/30/2023 | TERN | Buy Now | Terns Pharma | $44.31 | -61.64% | → $17 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 06/26/2023 | BNTC | Buy Now | Benitec Biopharma | $12.16 | -67.12% | → $4 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 06/16/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $61 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 06/09/2023 | CRSP | Buy Now | CRISPR Therapeutics | $57.49 | 28.72% | $70 → $74 | Maintains | Market Outperform | Get Alert | |
| 05/18/2023 | BNTC | Buy Now | Benitec Biopharma | $12.16 | -67.12% | $4 → $4 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 05/16/2023 | TERN | Buy Now | Terns Pharma | $44.31 | -61.64% | $17 → $17 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 05/11/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $61 | Reiterates | Market Outperform → Market Outperform | Get Alert | |
| 05/11/2023 | MGNX | Buy Now | Macrogenics | $1.40 | 614.29% | $8 → $10 | Maintains | Market Outperform | Get Alert | |
| 05/10/2023 | EXEL | Buy Now | Exelixis | $41.49 | -42.15% | → $24 | Reiterates | → Market Outperform | Get Alert | |
| 05/09/2023 | CRSP | Buy Now | CRISPR Therapeutics | $57.49 | 21.76% | → $70 | Reiterates | → Market Outperform | Get Alert | |
| 05/05/2023 | RLAY | Buy Now | Relay Therapeutics | $8.22 | 191.79% | $28 → $24 | Maintains | Market Outperform | Get Alert | |
| 04/27/2023 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $61 | Reiterates | → Market Outperform | Get Alert | |
| 04/21/2023 | MNDY | Buy Now | Monday.Com | $153.88 | 36.47% | $200 → $210 | Maintains | Buy | Get Alert | |
| 04/19/2023 | RLAY | Buy Now | Relay Therapeutics | $8.22 | 240.43% | → $28 | Reiterates | → Market Outperform | Get Alert | |
| 04/17/2023 | CRSP | Buy Now | CRISPR Therapeutics | $57.49 | 21.76% | → $70 | Reiterates | → Market Outperform | Get Alert | |
| 03/30/2023 | TSHA | Buy Now | Taysha Gene Therapies | $5.81 | -31.15% | → $4 | Reiterates | → Market Outperform | Get Alert | |
| 03/29/2023 | TERN | Buy Now | Terns Pharma | $44.31 | -61.64% | → $17 | Reiterates | → Market Outperform | Get Alert | |
| 03/24/2023 | VOR | Buy Now | Vor Biopharma | $13.40 | -10.45% | → $12 | Reiterates | → Market Outperform | Get Alert | |
| 03/24/2023 | GBIO | Buy Now | Generation Bio | $5.36 | 30.6% | → $7 | Reiterates | → Market Outperform | Get Alert | |
| 03/16/2023 | MGNX | Buy Now | Macrogenics | $1.40 | 471.43% | → $8 | Reiterates | → Market Outperform | Get Alert | |
| 03/13/2023 | CLLS | Buy Now | Cellectis | $4.73 | 26.85% | → $6 | Reiterates | → Market Outperform | Get Alert | |
| 03/06/2023 | GBIO | Buy Now | Generation Bio | $5.36 | -58.4% | $7 → $2.23 | Maintains | Market Outperform | Get Alert | |
| 02/27/2023 | CRSP | Buy Now | CRISPR Therapeutics | $57.49 | 21.76% | → $70 | Reiterates | → Market Outperform | Get Alert | |
| 02/14/2023 | TERN | Buy Now | Terns Pharma | $44.31 | -61.64% | → $17 | Initiates | → Market Outperform | Get Alert | |
| 02/13/2023 | VOR | Buy Now | Vor Biopharma | $13.40 | -10.45% | → $12 | Reiterates | → Market Outperform | Get Alert | |
| 02/01/2023 | TSHA | Buy Now | Taysha Gene Therapies | $5.81 | -31.15% | $6 → $4 | Maintains | Market Outperform | Get Alert | |
| 01/26/2023 | TWO | Buy Now | Two Harbors Inv | $9.88 | 82.28% | $17.5 → $18 | Maintains | Market Outperform | Get Alert | |
| 01/19/2023 | VOR | Buy Now | Vor Biopharma | $13.40 | -10.45% | $15 → $12 | Maintains | Market Outperform | Get Alert | |
| 01/19/2023 | TSHA | Buy Now | Taysha Gene Therapies | $5.81 | 3.27% | $20 → $6 | Maintains | Market Outperform | Get Alert | |
| 01/19/2023 | RLAY | Buy Now | Relay Therapeutics | $8.22 | 240.43% | $38 → $28 | Maintains | Market Outperform | Get Alert | |
| 01/19/2023 | MGNX | Buy Now | Macrogenics | $1.40 | 471.43% | $18 → $8 | Maintains | Market Outperform | Get Alert | |
| 01/19/2023 | GBIO | Buy Now | Generation Bio | $5.36 | 30.6% | $11 → $7 | Maintains | Market Outperform | Get Alert | |
| 01/19/2023 | EXEL | Buy Now | Exelixis | $41.49 | -42.15% | $25 → $24 | Maintains | Market Outperform | Get Alert | |
| 01/19/2023 | CRSP | Buy Now | CRISPR Therapeutics | $57.49 | 21.76% | $100 → $70 | Maintains | Market Outperform | Get Alert | |
| 01/19/2023 | CLLS | Buy Now | Cellectis | $4.73 | 26.85% | $11 → $6 | Maintains | Market Outperform | Get Alert | |
| 01/19/2023 | NTLA | Buy Now | Intellia Therapeutics | $9.18 | — | — | Downgrade | Market Outperform → Market Perform | Get Alert | |
| 12/09/2022 | EXEL | Buy Now | Exelixis | $41.49 | -39.74% | $26 → $25 | Maintains | Market Outperform | Get Alert | |
| 11/10/2022 | TSHA | Buy Now | Taysha Gene Therapies | $5.81 | 244.23% | $22 → $20 | Maintains | Market Outperform | Get Alert | |
| 10/18/2022 | BNTC | Buy Now | Benitec Biopharma | $12.16 | -67.12% | → $4 | Initiates | → Market Outperform | Get Alert | |
| 10/18/2022 | EXEL | Buy Now | Exelixis | $41.49 | -37.33% | → $26 | Initiates | → Market Outperform | Get Alert | |
| 09/19/2022 | NTLA | Buy Now | Intellia Therapeutics | $9.18 | 1109.81% | $106 → $111 | Maintains | Market Outperform | Get Alert | |
| 09/14/2022 | RLAY | Buy Now | Relay Therapeutics | $8.22 | 362.01% | $35 → $38 | Maintains | Market Outperform | Get Alert | |
| 08/08/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | $90 → $110 | Maintains | Market Outperform | Get Alert | |
| 08/08/2022 | GBIO | Buy Now | Generation Bio | $5.36 | 105.22% | $10 → $11 | Maintains | Market Outperform | Get Alert | |
| 07/12/2022 | MGNX | Buy Now | Macrogenics | $1.40 | 1328.57% | $24 → $20 | Maintains | Market Outperform | Get Alert | |
| 06/07/2022 | MRTX | Buy Now | Mirati Therapeutics | — | — | → $72 | Upgrade | Market Perform → Market Outperform | Get Alert | |
| 05/13/2022 | VOR | Buy Now | Vor Biopharma | $13.40 | 11.94% | $30 → $15 | Maintains | Market Outperform | Get Alert | |
| 05/11/2022 | CRSP | Buy Now | CRISPR Therapeutics | $57.49 | 73.94% | $150 → $100 | Maintains | Market Outperform | Get Alert | |
| 05/10/2022 | LOGC | Buy Now | LogicBio Therapeutics | $8.05 | -62.73% | $2 → $3 | Maintains | Market Outperform | Get Alert | |
| 05/09/2022 | RLAY | Buy Now | Relay Therapeutics | $8.22 | 325.53% | $50 → $35 | Maintains | Market Outperform | Get Alert | |
| 05/09/2022 | NTLA | Buy Now | Intellia Therapeutics | $9.18 | 1098.91% | $165 → $110 | Maintains | Market Outperform | Get Alert | |
| 04/01/2022 | TSHA | Buy Now | Taysha Gene Therapies | $5.81 | 519.62% | $44 → $36 | Maintains | Market Outperform | Get Alert | |
| 03/16/2022 | VOR | Buy Now | Vor Biopharma | $13.40 | 123.88% | $40 → $30 | Maintains | Market Outperform | Get Alert | |
| 01/07/2022 | NTLA | Buy Now | Intellia Therapeutics | $9.18 | 1698.37% | $175 → $165 | Maintains | Market Outperform | Get Alert | |
| 12/15/2021 | GBIO | Buy Now | Generation Bio | $5.36 | 86.57% | $40 → $10 | Maintains | Market Outperform | Get Alert | |
| 11/30/2021 | CLLS | Buy Now | Cellectis | $4.73 | 322.83% | → $20 | Initiates | → Market Outperform | Get Alert | |
| 11/16/2021 | LOGC | Buy Now | LogicBio Therapeutics | $8.05 | 98.76% | $17 → $16 | Maintains | Market Outperform | Get Alert | |
| 11/11/2021 | TSHA | Buy Now | Taysha Gene Therapies | $5.81 | 554.04% | $40 → $38 | Maintains | Market Outperform | Get Alert | |
| 11/03/2021 | MGNX | Buy Now | Macrogenics | $1.40 | 2614.29% | $39 → $38 | Maintains | Market Outperform | Get Alert | |
| 10/19/2021 | VOR | Buy Now | Vor Biopharma | $13.40 | 198.51% | → $40 | Initiates | → Market Outperform | Get Alert | |
| 10/19/2021 | MGNX | Buy Now | Macrogenics | $1.40 | 2685.71% | → $39 | Initiates | → Market Outperform | Get Alert | |
| 10/11/2021 | TPTX | Buy Now | Turning Point | — | — | — | Downgrade | Market Outperform → Market Perform | Get Alert | |
| 08/06/2021 | NTLA | Buy Now | Intellia Therapeutics | $9.18 | 1807.36% | $160 → $175 | Maintains | Market Outperform | Get Alert | |
| 06/29/2021 | NTLA | Buy Now | Intellia Therapeutics | $9.18 | 1262.4% | $73 → $125 | Maintains | Perform | Get Alert | |
| 06/23/2021 | NTLA | Buy Now | Intellia Therapeutics | $9.18 | 859.13% | $80 → $88 | Maintains | Market Outperform | Get Alert | |
| 06/08/2021 | GBIO | Buy Now | Generation Bio | $5.36 | 646.27% | → $40 | Initiates | → Market Outperform | Get Alert | |
| 06/08/2021 | TSHA | Buy Now | Taysha Gene Therapies | $5.81 | 588.47% | → $40 | Initiates | → Market Outperform | Get Alert | |
| 03/04/2021 | LOGC | Buy Now | LogicBio Therapeutics | $8.05 | 111.18% | → $17 | Initiates | → Outperform | Get Alert | |
| 03/04/2021 | NTLA | Buy Now | Intellia Therapeutics | $9.18 | 771.93% | → $80 | Initiates | → Outperform | Get Alert | |
| 03/04/2021 | CRSP | Buy Now | CRISPR Therapeutics | $57.49 | 178.31% | → $160 | Initiates | → Outperform | Get Alert | |
| 12/08/2020 | TPTX | Buy Now | Turning Point | — | — | → $125 | Initiates | → Market Outperform | Get Alert | |
| 12/08/2020 | RLAY | Buy Now | Relay Therapeutics | $8.22 | 702.43% | → $66 | Initiates | → Market Outperform | Get Alert | |
| 12/08/2020 | MRTX | Buy Now | Mirati Therapeutics | — | — | — | Initiates | → Market Perform | Get Alert | |
| 09/21/2020 | EXEL | Buy Now | Exelixis | $41.49 | -10.82% | $33 → $37 | Maintains | Outperform | Get Alert | |
| 09/08/2020 | CNST | Buy Now | Constellation | — | — | — | Downgrade | Outperform → Perform | Get Alert | |
| 06/30/2020 | SGEN | Buy Now | Seagen | — | — | $200 → $210 | Maintains | Outperform | Get Alert | |
| 06/26/2020 | SGEN | Buy Now | Seagen | — | — | $175 → $200 | Maintains | Outperform | Get Alert | |
| 06/01/2020 | SGEN | Buy Now | Seagen | — | — | $146 → $175 | Maintains | Outperform | Get Alert | |
| 06/01/2020 | EXEL | Buy Now | Exelixis | $41.49 | -22.87% | $28 → $32 | Maintains | Outperform | Get Alert | |
| 04/21/2020 | EXEL | Buy Now | Exelixis | $41.49 | -32.51% | $25 → $28 | Maintains | Outperform | Get Alert | |
| 04/20/2020 | SGEN | Buy Now | Seagen | — | — | $124 → $146 | Maintains | Outperform | Get Alert | |
| 02/28/2020 | NTLA | Buy Now | Intellia Therapeutics | $9.18 | — | — | Upgrade | Perform → Outperform | Get Alert | |
| 12/12/2019 | SGEN | Buy Now | Seagen | — | — | $110 → $124 | Maintains | Outperform | Get Alert | |
| 10/22/2019 | SGEN | Buy Now | Seagen | — | — | $92 → $110 | Maintains | Outperform | Get Alert | |
| 10/01/2019 | SGEN | Buy Now | Seagen | — | — | $82 → $92 | Maintains | Outperform | Get Alert | |
| 09/12/2019 | SGEN | Buy Now | Seagen | — | — | $77 → $82 | Upgrade | Perform → Outperform | Get Alert | |
| 04/02/2019 | CNST | Buy Now | Constellation | — | — | $14 → $18 | Maintains | Outperform | Get Alert | |
| 08/13/2018 | CNST | Buy Now | Constellation | — | — | → $21 | Initiates | → Outperform | Get Alert | |
| 03/08/2018 | NTLA | Buy Now | Intellia Therapeutics | $9.18 | 728.34% | → $76 | Initiates | → Market Outperform | Get Alert | |
| 03/08/2018 | CRSP | Buy Now | CRISPR Therapeutics | $57.49 | 20.02% | → $69 | Initiates | → Market Outperform | Get Alert | |
| 06/16/2014 | MRTX | Buy Now | Mirati Therapeutics | — | — | $25 → $28 | Maintains | Market Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved